WARTS
Clinical trials for WARTS explained in plain language.
Never miss a new study
Get alerted when new WARTS trials appear
Sign up with your email to follow new studies for WARTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a stem cell drug tame rare immune disease?
Disease control Recruiting nowThis early-phase study tests whether Mozobil, a drug already used to boost stem cells for transplants, can safely raise white blood cell counts in people with WHIMS. WHIMS is a rare genetic condition that traps infection-fighting cells in the bone marrow, leading to frequent infe…
Matched conditions: WARTS
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New hope for stubborn warts: extended treatment shows promise
Disease control Recruiting nowThis study follows people who already took part in earlier YCANTH wart studies. It tests whether up to 4 more treatments, applied every 21 days, can safely clear common warts. About 600 adults and children will be monitored for a year. The goal is to see if the medicine continues…
Matched conditions: WARTS
Phase: PHASE3 • Sponsor: Verrica Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Heat and hydrogen peroxide patch takes on stubborn warts
Disease control Recruiting nowThis study tests whether adding a microneedle patch soaked in hydrogen peroxide to local heat therapy can clear viral warts better than heat alone. About 210 people aged 6–65 with common or plantar warts will be split into three groups: heat only, heat plus a plain patch, or heat…
Matched conditions: WARTS
Phase: NA • Sponsor: First Hospital of China Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New gel could zap away common warts in just weeks
Disease control Recruiting nowThis study tests a gel called YCANTH on common warts caused by HPV. About 300 people aged 2 and older with at least one wart will apply the gel or a fake version. The goal is to see if the gel can clear all warts by day 84.
Matched conditions: WARTS
Phase: PHASE3 • Sponsor: Verrica Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Scientists launch Long-Term study to unravel mysterious immune condition
Knowledge-focused Recruiting nowThis study follows 950 people with idiopathic CD4+ lymphocytopenia (ICL), a rare condition where low CD4+ white blood cells raise infection risk. Researchers will track participants for up to 10 years, collecting medical history, blood samples, and infection data. The goal is to …
Matched conditions: WARTS
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC